New Report Shows Brand Drug Product Hopping Costs Billions for Patients and Healthcare System Each Year
Report details five instances of product hopping that collectively cost $4.7 billion annually.
Report details five instances of product hopping that collectively cost $4.7 billion annually.
A new report released today by Matrix Global Advisors (MGA) finds that COVID-19 is likely as severe as the 1918 pandemic, the worst pandemic in the twentieth century. MGA evaluated COVID-19 data using the Centers for Disease Control and Prevention’s Pandemic Severity Assessment Framework (PSAF) and found that the current pandemic’s clinical severity (how sick the virus makes people) and transmissibility (how contagious the virus is) are the highest measurable by that tool.